Educational Objectives


By the end of the 5-day educational program, the participants will be able to:

  • dissect the basic mechanisms of thrombosis and venous thromboembolism (VTE);

  • translate the knowledge from experimental research (in vitro and in vivo models) to the pathophysiology of acute and chronic VTE in humans;

  • identify the predisposing factors for VTE in different patient populations;

  • understand the association between thrombosis and cancer;

  • employ scores and prediction rules in the diagnosis and risk stratification of VTE;

  • assess and define the severity of acute VTE and the need for advanced therapy in a given patient;

  • choose between the available medical and interventional options for the treatment of acute right heart failure;

  • determine the appropriate management strategy in challenging cases and vulnerable patient populations;

  • gain deeper insights into the modalities, duration, and possible bleeding complications of anticoagulation as well as into the role of the laboratory in the management of anticoagulated patients with VTE;

  • implement guideline recommendations to the diagnosis and treatment of chronic thromboembolic pulmonary hypertension;

  • evaluate the design and interpret the statistical analysis plan of clinical trials;

  • appreciate the contribution of large cohorts and biodata banking to state-of-the-art VTE research;

  • network with international experts and early-stage researchers/physicians in the field of thrombosis and venous thromboembolism.